Sio Gene Therapies Inc.

NASDAQ:SIOX

0.415 (USD) • At close July 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2022202120202019201820172016
Operating Activities:
Net Income -71.887-32.425-72.628-129.065-221.573-180.951-133.145
Depreciation & Amortization 0.6662.4663.0942.453.0830.2490.014
Deferred Income Tax 0-10.866-0.94702.709-2.386-0.323
Stock Based Compensation 7.4254.4927.89516.42931.87836.3772.386
Change In Working Capital 3.86-9.474-3.305-19.083-3.50831.8452.146
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 2.643-3.0712.71-2.251-4.6027.9290.219
Other Working Capital 1.217-6.403-6.015-16.8321.09423.9161.927
Other Non Cash Items -0.41-0.782-1.582-4.938-2.9372.7645.575
Operating Cash Flow -60.346-46.589-67.473-134.207-190.348-112.109-53.347
Investing Activities:
Investments In Property Plant And Equipment -0.695-0.398-0.255-0.202-4.284-0.105-5.346
Acquisitions Net 0000000
Purchases Of Investments 0000000
Sales Maturities Of Investments 4.34312.78400000
Other Investing Activites 0000000
Investing Cash Flow 3.64812.386-0.255-0.202-4.284-0.105-5.346
Financing Activities:
Debt Repayment 0-15.731-29.563-9.70700-0.627
Common Stock Issued 1.44189.23170.8194.549134.5150336.893
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 00.1210.2342.2291.88148.536-1.322
Financing Cash Flow 1.44173.62141.48187.071136.39648.536334.944
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -55.25739.418-26.247-47.338-58.236-63.678276.251
Cash At End Of Period 64.913120.1780.752106.999154.337212.573276.251